How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making
Innovations in vaccine product attributes could play an important role in addressing coverage and equity (C&E) gaps, but there is currently a poor understanding of the full system impact and trade-offs associated with investing in such technologies, both from the perspective of national immunisa...
Main Authors: | Siobhan Botwright, Anna-Lea Kahn, Raymond Hutubessy, Patrick Lydon, Joseph Biey, Abdoul Karim Sidibe, Ibrahima Diarra, Mardiati Nadjib, Auliya A. Suwantika, Ery Setiawan, Rachel Archer, Debra Kristensen, Marion Menozzi-Arnaud, Ado Mpia Bwaka, Jason M. Mwenda, Birgitte K. Giersing |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136220300255 |
Similar Items
-
Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study
by: Sofieke Klamer, et al.
Published: (2021-01-01) -
National Immunization Program Decision Making Using the CAPACITI Decision-Support Tool: User Feedback from Indonesia and Ethiopia
by: Maarten Jansen, et al.
Published: (2024-03-01) -
Note sur des essais d'immunisation de lapins contre des tsé-tsé, <em>Glossina fuscipes fuscipes</em> (Diptera : Glossinidae)
by: Marc Desquesnes
Published: (1990-04-01) -
Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021–2030
by: Salin Sriudomporn, et al.
Published: (2023-04-01) -
Immunisation
by: B Farham
Published: (2023-04-01)